← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 1997Last known activity
Oct 6, 2015
Timeline
1980s
- Jan 1, 1985
CytRx— Founded
2000s
- Oct 4, 2004
Biorex Research and Development— Acquired
- Sep 22, 2008
Innovive Pharmaceuticals— Acquired
Drugs by trial phase (27 distinct, 49 trials)
Phase 4 (0 own, 2 via acquisition)
Phase 3 (8 own, 2 via acquisition)
Phase 2 (4 own, 4 via acquisition)
Phase 1 (1 own, 5 via acquisition)
Other trials (0 own, 1 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Amyotrophic Lateral Sclerosis
- Anemia, Sickle Cell
- Carcinoma, Non-Small-Cell Lung
- Glioblastoma
- HIV Seropositivity
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Promyelocytic, Acute
- Lung Neoplasms
- Motor Neuron Disease
- Neoplasms
- Pleural Effusion
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Sarcoma
- Sarcoma, Kaposi
- Sclerosis
- Small Cell Lung Carcinoma
Subsidiaries (2 direct, 3 total across the full acquisition tree)
Recent trials (31)
- NCT02570412Lead sponsorN/AOct 6, 2015
- NCT02200757Lead sponsorPhase 2Sep 1, 2014
- NCT02235688Lead sponsorPhase 1Aug 1, 2014
- NCT02235701Lead sponsorPhase 1/Phase 2Aug 1, 2014
- NCT02235701Study directorPhase 1/Phase 2Aug 1, 2014
- NCT02235688Study directorPhase 1Aug 1, 2014
- NCT02014844Lead sponsorPhase 2Mar 1, 2014
- NCT02049905Lead sponsorPhase 3Jan 1, 2014
- NCT02029430Lead sponsorPhase 2Jan 1, 2014
- NCT01706835Study directorPhase 1Oct 1, 2012
- NCT01706835Lead sponsorPhase 1Oct 1, 2012
- NCT01673438Study directorPhase 1Jul 1, 2012
- NCT01673438Lead sponsorPhase 1Jul 1, 2012
- NCT01580397Study directorPhase 2May 1, 2012
- NCT01580397Lead sponsorPhase 2May 1, 2012
Details
- Founded
- Los Angelos, CA, US Jan 1, 1985
- Last known activity
- Oct 6, 2015